Patents by Inventor Scott W. Henry

Scott W. Henry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modulation of HIF1-beta expression
    Patent number: 7799764
    Abstract: Compounds, compositions and methods are provided for modulating the expression of HIF1-beta. The compositions comprise oligonucleotides, targeted to nucleic acid encoding HIF1-beta. Methods of using these compounds for modulation of HIF1-beta expression and for diagnosis and treatment of diseases and conditions associated with expression of HIF1-beta are provided.
    Type: Grant
    Filed: October 13, 2009
    Date of Patent: September 21, 2010
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Eric G. Marcusson, Scott W. Henry, Youngsoo Kim, Kenneth Dobie
  • MODULATION OF HIF1 BETA EXPRESSION
    Publication number: 20100113573
    Abstract: Compounds, compositions and methods are provided for modulating the expression of HIF1-beta. The compositions comprise oligonucleotides, targeted to nucleic acid encoding HIF1-beta. Methods of using these compounds for modulation of HIF1-beta expression and for diagnosis and treatment of diseases and conditions associated with expression of HIF1-beta are provided.
    Type: Application
    Filed: October 13, 2009
    Publication date: May 6, 2010
    Applicant: Isis Pharmaceuticals, Inc.
    Inventors: Eric G. Marcusson, Scott W. Henry, Youngsoo Kim, Kenneth Dobie
  • Modulation of HIF-1 beta expression
    Patent number: 7618947
    Abstract: Compounds, compositions and methods are provided for modulating the expression of HIF1-beta. The compositions comprise oligonucleotides, targeted to nucleic acid encoding HIF1-beta. Methods of using these compounds for modulation of HIF1-beta expression and for diagnosis and treatment of diseases and conditions associated with expression of HIF1-beta are provided.
    Type: Grant
    Filed: August 25, 2005
    Date of Patent: November 17, 2009
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Eric G. Marcusson, Scott W. Henry, Youngsoo Kim, Kenneth W. Dobie